NCT06243757View on ClinicalTrials.gov

A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers

Active, not recruitingOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

January 8, 2036

Study Completion Date

January 8, 2036

Conditions
Gastric CancerGastroEsophageal CancerGastroesophageal Junction Adenocarcinoma
Interventions
OTHER

MDASI-GI

"The MDASI-GI assesses 5 symptoms specific to gastrointestinal cancer:~constipation diarrhea or watery stools difficulty swallowing change in taste feeling bloated~Using this questionnaire, participants score the severity of their symptoms over the previous 24 hours on a scale of 0 (not present) to 10 (as bad as you can imagine)."

Trial Locations (8)

10065

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

10604

Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison

11553

Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre

11725

Memorial Sloan Kettering Commack (All Protocol Activities), Commack

77030

MD Anderson Cancer Center (Data Analysis Only), Houston

07920

Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge

07748

Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown

07645

Memorial Sloan Kettering Bergen (All protocol activities), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER